Publications by authors named "Scott Berkowitz"

Claim this Profile
R
Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD.
Shea Hogan, Michael Szarek, E Sebastian Debus, Mark Nehler, Sonia S Anand, Scott E Berkowitz

J Am Heart Assoc· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Social Determinants of Cardiovascular Aging.
Aaron L Troy, Anjali Bhatla, Scott A Berkowitz, Roger S Blumenthal, Thomas K M Cudjoe

JACC Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Antithrombotic Therapy in Patients With Chronic Coronary Syndrome: An Updated Review of Current Evidence.
Mario Enrico Canonico, Marisa Avvedimento, Raffaele Piccolo, Connie N Hess, Luca Bardi, Scott D Berkowitz

Clin Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescription of aspirin plus low-dose rivaroxaban in patients with peripheral artery disease after lower-extremity revascularization.
Mario Enrico Canonico, Connie N Hess, Sivan Naveh, R Kevin Rogers, Mark R Nehler, Scott D Berkowitz

Vasc Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Risk of Major Adverse Limb Events Following Lower Extremity Revascularization in the VOYAGER-PAD Trial.
R Kevin Rogers, Eike Sebastian Debus, Manesh R Patel, Sonia S Anand, Eva Muehlhofer, Scott D Berkowitz

JACC Cardiovasc Interv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scaling the Diabetes Prevention Program and Diabetes Self-Management Education and Support Services Across a Health System.
Nisa M Maruthur, Siawlin Chan, Eugene Arnold, Megan Brown, Caitlin Nass, Scott A Berkowitz

Clin Diabetes· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations for Academic Medical Centers Moving AHEAD.
Anjali Bhatla, Scott A Berkowitz

JAMA Health Forum· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower Extremity Revascularization.
Mario Enrico Canonico, Cecilia C Low Wang, Judith Hsia, E Sebastian Debus, Mark R Nehler, Scott D Berkowitz

J Am Coll Cardiol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis.
Josephine Harrington, Anne S Hellkamp, Kenneth W Mahaffey, Günter Breithardt, Jonathan L Halperin, Scott D Berkowitz

J Am Heart Assoc· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between opioid use disorder and skilled nursing facility acceptances: A multicenter retrospective cohort study.
Ifedayo O Kuye, Laura M Prichett, Rosalyn W Stewart, Scott A Berkowitz, Megan E Buresh

J Hosp Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.
Justin T Morrison, Mario Enrico Canonico, Sonia S Anand, Manesh R Patel, Eike Sebastian Debus, Scott D Berkowitz

Circulation· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods, design, and initial results of an angiographic core lab from VOYAGER-PAD.
R Kevin Rogers, Joerg Herold, Nicholas Govsyeyev, Roberto Iezzi, Justin Morrison, Scott D Berkowitz

Vasc Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial.
Zhong Yuan, Bennett Levitan, Hsiaowei Deng, Michael Szarek, Rupert M Bauersachs, Scott D Berkowitz

J Am Heart Assoc· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD.
Shea E Hogan, Eike Sebastian Debus, Mark R Nehler, Manesh R Patel, Sonia S Anand, Scott D Berkowitz

Circulation· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventing Avoidable Rehospitalizations through Standardizing Management of Chronic Conditions in Skilled Nursing Facilities.
Ya Luan Hsiao, Eric B Bass, Albert W Wu, Denise Kelly, Carol Sylvester, Scott A Berkowitz

J Am Med Dir Assoc· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD.
Jennifer Rymer, Sonia S Anand, E Sebastian Debus, Lloyd P Haskell, Connie N Hess, Scott D Berkowitz

Circulation· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transforming Health Care from Volume to Value: Moving the Needle Through Population Health.
Sarah J Conway, Ifedayo O Kuye, John Yeatts, Jonathan Jaffery, Scott A Berkowitz

Am J Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transforming Health Care from Volume to Value: A Health System Implementation Road Map.
Pamela T Johnson, Sarah J Conway, Scott A Berkowitz, Armin Arbab-Zadeh, Lee H Riley

Am J Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Health System, Provider, and Payer Opportunities in Population Health Delivery.
Jonathan E Eldridge, Scott A Berkowitz

Popul Health Manag· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Planning for the future of population health: the Johns Hopkins Medicine experience.
Scott A Berkowitz, Teodoro Norman, Kevin W Sowers

Am J Manag Care· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits.
Nicholas Govsyeyev, Mark Nehler, Michael S Conte, Sebastian Debus, Jayer Chung, Scott D Berkowitz

J Vasc Surg· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions.
Mario Enrico Canonico, Raffaele Piccolo, Marisa Avvedimento, Attilio Leone, Salvatore Esposito, Scott D Berkowitz

J Cardiovasc Dev Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a "CASPAR like" outcome from VOYAGER PAD.
Marc P Bonaca, Michael Szarek, E Sebastian Debus, Mark R Nehler, Manesh R Patel, Scott D Berkowitz

Clin Cardiol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers to acute care discharge from an urban center before and during the COVID-19 pandemic.
Grace Xiao, Sara Wallam, Ruiyi Gao, Nicholas E Henlon, Allison A Hart, Scott A Berkowitz

Brown J Hosp Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization.
Connie N Hess, Michael Szarek, Sonia S Anand, Rupert M Bauersachs, Manesh R Patel, Scott D Berkowitz

JAMA Netw Open· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis